BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 12825947)

  • 1. Bioactive peptidic analogues and cyclostereoisomers of the minimal antinociceptive histogranin fragment-(7-10).
    Le HT; Lemaire IB; Gilbert AK; Jolicoeur F; Lemaire S
    J Med Chem; 2003 Jul; 46(14):3094-101. PubMed ID: 12825947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histogranin-like antinociceptive and anti-inflammatory derivatives of o-phenylenediamine and benzimidazole.
    Le HT; Lemaire IB; Gilbert AK; Jolicoeur F; Yang L; Leduc N; Lemaire S
    J Pharmacol Exp Ther; 2004 Apr; 309(1):146-55. PubMed ID: 14718586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-opioid antinociceptive effects of supraspinal histogranin and related peptides: possible involvement of central dopamine D(2) receptor.
    Ruan H; Prasad JA; Lemaire S
    Pharmacol Biochem Behav; 2000 Sep; 67(1):83-91. PubMed ID: 11113487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DAMGO and 6beta-glycine substituted 14-O-methyloxymorphone but not morphine show peripheral, preemptive antinociception after systemic administration in a mouse visceral pain model and high intrinsic efficacy in the isolated rat vas deferens.
    Al-Khrasani M; Spetea M; Friedmann T; Riba P; Király K; Schmidhammer H; Furst S
    Brain Res Bull; 2007 Oct; 74(5):369-75. PubMed ID: 17845912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analgesic effect of TT-232, a heptapeptide somatostatin analogue, in acute pain models of the rat and the mouse and in streptozotocin-induced diabetic mechanical allodynia.
    Szolcsányi J; Bölcskei K; Szabó A; Pintér E; Petho G; Elekes K; Börzsei R; Almási R; Szuts T; Kéri G; Helyes Z
    Eur J Pharmacol; 2004 Sep; 498(1-3):103-9. PubMed ID: 15363982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid activities of D-Arg2-substituted tetrapeptides.
    Sato T; Sakurada S; Sakurada T; Furuta S; Chaki K; Kisara K; Sasaki Y; Suzuki K
    J Pharmacol Exp Ther; 1987 Aug; 242(2):654-9. PubMed ID: 3612556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonopioid motor effects of dynorphin A and related peptides: structure dependence and role of the N-methyl-D-aspartate receptor.
    Shukla VK; Prasad JA; Lemaire S
    J Pharmacol Exp Ther; 1997 Nov; 283(2):604-10. PubMed ID: 9353375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of novel bicyclic analogues derived from a potent oxytocin antagonist.
    Flouret G; Chaloin O; Borovickova L; Slaninová J
    J Pept Sci; 2006 Jun; 12(6):412-9. PubMed ID: 16432806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive activity of some peptides related to cycloamanide A (CyA A) and to the active fragment of a peptide immunomodulator from ovine colostrum.
    Bolewska-Pedyczak E; Wieczorek Z; Zimecki M; Siemion IZ
    Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):297-301. PubMed ID: 8010869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antinociceptive, brain-penetrating derivatives related to improgan, a non-opioid analgesic.
    Hough LB; Nalwalk JW; Lu Q; Shan Z; Svokos K; Wentland MP; Montero MJ
    Eur J Pharmacol; 2005 Oct; 522(1-3):38-46. PubMed ID: 16216240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual effects of [Tyr(6)]-gamma2-MSH(6-12) on pain perception and in vivo hyperalgesic activity of its analogues.
    Wei C; Huang W; Xing X; Dong S
    J Pept Sci; 2010 Sep; 16(9):451-5. PubMed ID: 20629198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further investigations on the antinociceptive activity of tuftsin analogs.
    Nawrocka-Bolewska E; Kubik A; Szewczuk Z; Siemion IZ; Obuchowicz E; Gołba K; Herman ZS
    Pol J Pharmacol Pharm; 1991; 43(4):281-8. PubMed ID: 1811220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological effects of c(Lys-Lys-Pro-Tyr-Ile-Leu-Lys-Lys-Pro-Tyr-Ile-Leu) (JMV2012), a new analogue of neurotensin that crosses the blood-brain barrier.
    Bredeloux P; Cavelier F; Dubuc I; Vivet B; Costentin J; Martinez J
    J Med Chem; 2008 Mar; 51(6):1610-6. PubMed ID: 18321036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-Ala2,F5Phe4-dynorphin amide, an opiate with analgesic and toxic properties.
    Kostrzewa RM; Brus R; Coy DH; Criswell H; Coogan PS; Kastin AJ
    Pol J Pharmacol Pharm; 1992; 44(2):109-20. PubMed ID: 1357636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo design, synthesis, and pharmacology of alpha-melanocyte stimulating hormone analogues derived from somatostatin by a hybrid approach.
    Han G; Haskell-Luevano C; Kendall L; Bonner G; Hadley ME; Cone RD; Hruby VJ
    J Med Chem; 2004 Mar; 47(6):1514-26. PubMed ID: 14998337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic enkephalin analogues with exceptional potency and selectivity for delta-opioid receptors.
    Hruby VJ; Bartosz-Bechowski H; Davis P; Slaninova J; Zalewska T; Stropova D; Porreca F; Yamamura HI
    J Med Chem; 1997 Nov; 40(24):3957-62. PubMed ID: 9397176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of potent, highly selective vasopressin hypotensive agonists.
    Stoev S; Cheng LL; Manning M; Wo NC; Szeto HH
    J Pept Sci; 2006 Sep; 12(9):592-604. PubMed ID: 16625682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enkephalin derivative, cyclo[Nepsilon,Nbeta-carbonyl-D-Lys2, Dap5] enkephalinamide (cUENK6), induces a highly potent antinociception in rats.
    Kotlinska J; Bochenski M; Lagowska-Lenard M; Gibula-Bruzda E; Witkowska E; Izdebski J
    Neuropeptides; 2009 Jun; 43(3):221-8. PubMed ID: 19376576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutual antagonism between nerve growth factor and substance P N-terminal activity on nociceptive activity in mice.
    Larson AA; Kitto KF
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1345-50. PubMed ID: 9316845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.